...
首页> 外文期刊>Journal of bone and mineral metabolism >Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosis.
【24h】

Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosis.

机译:GALNT3中的新突变导致高磷酸盐血症性家族性肿瘤性钙化病。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Hyperphosphatemic familial tumoral calcinosis (HFTC) is known to be caused by mutations in at least three genes: FGF23, GALNT3 and KL. Two families with two affected members suffering from HFTC were scrutinized for mutations in these candidate genes. We identified in both families homozygous missense mutations affecting highly conserved amino acids in GALNT3. One of the mutations is a novel mutation, whereas the second mutation was reported before in a compound heterozygous state. Our data expand the spectrum of known mutations in GALNT3 and contribute to a better understanding of the phenotypic manifestations of mutations in this gene.
机译:已知高磷酸盐血症性家族性肿瘤性钙化病(HFTC)是由至少三个基因的突变引起的:FGF23,GALNT3和KL。对两个有HFTC受影响成员的两个家庭进行了仔细检查,检查这些候选基因的突变。我们在两个家族中鉴定了影响GALNT3中高度保守氨基酸的纯合错义突变。突变之一是新突变,而先前报道的第二突变是复合杂合状态。我们的数据扩大了GALNT3中已知突变的范围,并有助于更好地了解该基因突变的表型表现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号